Birchbrook’s Gilead Sciences GILD Stock Holding History

Birchbrook’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-582	Closed	-$39.9K	–	275
2024 Q2	$39.9K	Hold	582	–	–	0.02%	129
2024 Q1	$42.6K	Hold	582	–	–	0.03%	129
2023 Q4	$47.1K	Buy	+582	New	+$45.3K	0.03%	125

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Birchbrook's GILD Position: Q3 2024 in Review

Birchbrook sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 582 shares — an estimated $39.9K sold.

Birchbrook first reported a position in GILD in Q4 2023 and held it in 3 quarters. The position peaked at $47.1K in Q4 2023. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Birchbrook reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Birchbrook sold 582 Gilead Sciences shares in Q3 2024, an estimated $39.9K.
Birchbrook first reported a position in Gilead Sciences in Q4 2023 and held it in 3 quarters.
Birchbrook's Gilead Sciences position peaked at $47.1K in Q4 2023.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Birchbrook's 13F filing for Q3 2024, filed 10 Jun 2025.